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ABSTRACT
A case of acute ischemic stroke following pacemaker implan-
tation treated via endovascular intervention together with 
intra-arterial thrombolysis has been presented. Through right 
radial access, proximal thrombotic occlusion of the left M1 
segment of the middle cerebral artery was confirmed within 
2.5 hours of symptoms onset. The Sion Blue wire was placed 
through the thrombus in the distal region of the artery and then 
the thrombus was aspirated with Finecross microcatheter. At 
the end of the procedure through the microcatheter two selec-
tive intra-arterial boluses of 5 mg of Alteplase were injected. 
The patient was discharged 6 days after the intervention with 
Rankin score 2, without bleeding events.
Key words: ischemic stroke, thrombolysis, transcatheter 
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STRESZCZENIE
Przedstawiono przypadek ostrego udaru niedokrwiennego po 
implantacji kardiostymulatora, leczony za pomocą interwencji 
wewnątrznaczyniowej z  jednoczesnym lokalnym podaniem 
trombolizy. Po wprowadzeniu cewnika przez prawą tętnicę 
promieniową uwidoczniono proksymalne zamknięcie segmentu 
M1 lewej tętnicy środkowej mózgu w ciągu 2,5 godziny po 
wystąpieniu objawów. Następnie umieszczono prowadnik Sion 
Blue dystalnie do miejsca zakrzepu, a zakrzep zaaspirowano 
mikrocewnikiem Finecross. Po zakończeniu procedury poprzez 
mikrocewnik wstrzyknięto dotętniczo dwa bolusy Alteplazy po 
5 mg. Pacjent został wypisany do domu 6 dni po interwencji 
w stopniu według Rankina 2, bez zdarzeń krwotocznych.
Słowa kluczowe: udar niedokrwienny mózgu, tromboliza, 
przezcewnikowa interwencja wewnątrznaczyniowa
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Introduction
To date the only proven therapy for acute ischemic 
stroke is early recanalization [1]. This could be done 
either with administration of intravenous tissue 
plasminogen activator [2] or via endovascular inter-
vention, which includes intra-arterial thrombolysis [3] 
or mechanical thrombectomy [5–6].
It is estimated that stroke occurs in up to 2.9% of all 
patients who undergo general surgery [7].
Postoperative acute ischemic stroke is common in 
hospitalized patients. These patients have the benefit 
of early diagnosis and the burden of high bleeding 
risk after intravenous fibrinolysis. According to AHA/ 
/ASA Guideline major surgery is a relative contrain-
dication for systemic fibrinolysis. Intra-arterial throm-
bolysis (IAT) uses a lower dose and local delivery of 
lytic agent and accomplishes clot-specific lysis of 
occlusive thrombi with limited systemic plasminogen 
activation and may therefore be a viable therapeutic 
option in postoperative stroke patients.
Endovascular 
treatment of high 
bleeding risk 
acute ischemic 
stroke
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We present a case of postoperative acute ischemic 
stroke treated via endovascular intervention.
In July, 2016, a 78-year-old female with history of 
hypertension, hyperlipidemia, paroxysmal atrial 
fibrillation, was admitted to the emergency room 
because of AV block III degree. Ambulatory ther-
apy was just amlodipine and atorvastatin, with-
out bradycardic or antithrombotic medicines. She 
was conscious without any neurologic deficit. Be-
fore admission in our cardiology unit she received 
60 mg of enoxaparine subcutaneously. Prompt treat-
ment with implantation of pacemaker type DDD was 
performed. A  few hours after the procedure she 
experienced acute stroke with sudden weakness 
in her left arm and leg. Her NIHSS score was 10. 
We performed computed tomography (CT), which 
excluded hemorrhage and showed early ischemic 
changes in the territory of right middle cerebral 
artery (Figure 1). 
Because of the recent surgical intervention and the 
enoxaparine administration within 8 hours before 
acute stroke onset, we decided that the risk of intra-
venous fibrinolysis will be associated with high risk 
of bleeding and therefore endovascular treatment 
is the best option in these settings.
Diagnostic angiography started within 2.5 hours of 
symptoms onset. 
Through right radial access proximal thrombotic 
occlusion of her left M1 segment of the middle 
cerebral artery was confirmed (Figure 2 and 3). 
There was no stenosis in both extra- and intracere-
bral segments of carotid arteries. Flexor® Shuttle® 
Guiding Sheath was introduced from the right radial 
artery to the left common carotid artery. Sion Blue 
guidewire and microcatheter Finecross were used 
to reach M1 segment. The wire was placed through 
the thrombus in the distal region of the artery and 
then the microcatheter was advanced to perform 
several thrombo-aspirations. As a  result the flow 
in the artery was restored and the distal segments 
have been appeared. At the end of the procedure 
through the microcatheter two selective intra-ar-
terial boluses of 5 mg of Alteplase were injected 
(t-PA) (Figure 3 and 4). The blood flow in the artery 
was greatly improved and the neurologic state was 
getting better. Fortunately the patient did not have 
bleeding in the surgical incision or intracranial. She 
was discharged 6 days after the intervention with 
considerably lower neurologic symptoms, without 
bleeding events. We performed additional CT scan, 
which showed no complications. At discharge her 
Rankin score was 2. At 1 and 6 month follow up she 
did not have any adverse events.
Discussion
Intra-arterial fibrinolysis is considered for patients 
ineligible for intravenous thrombolysis. Compared 
with systemic therapy, intra-arterial therapy offers 
several advantages, including a higher concentration 
of lytic agent delivered to the clot target and lower 
systemic exposure to drug. Disadvantages include 
additional time required to initiate therapy, avail-
ability only at specialized centers, and mechanical 
manipulation within potentially injured vessels. In-
tra-arterial fibrinolysis or mechanical thrombectomy 
is reasonable in patients who have contraindications 
to the use of intravenous fibrinolysis (Class IIa; Level 
of Evidence C) [8]. The intra-arterial approach is 
thought to be more efficacious for recanalization 
of proximal arterial occlusions than intravenous 
Figure 1.
Figure 2.
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fibrinolysis, but the evidences for this approach are 
limited. Supportive evidence comes primarily from 
a cohort study by Mattle et al. [9]. They compared 
stroke outcomes at 2 stroke units, each of which 
treated exclusively with either intravenous rtPA or 
intra-arterial urokinase. Favorable outcomes (mRS 
score 0–2) have been found in 29 out of 55 (53%) 
intra-arterial versus in 13 out of 57 (23%) intravenous 
cases (P = 0.001).
Chalela et al. [10] presented published series of 36 
postoperative stroke patients treated with intra-ar-
terial thrombolytic therapy. The surgery was mostly 
major unlike our case. All patients had angiography 
performed within the average 5.5 hours of symptom 
onset, with thrombolysis completed within 8 hours of 
symptom onset. Like our case two thirds of strokes 
were due to cardioembolic mechanism. The most 
compelling finding in this study was that 2 patients 
had fatal intracranial hemorrhage when receiving in-
tra-arterial thrombolysis soon after craniotomy. Both 
hemorrhages were ipsilateral to the craniotomy site. 
Surgical site bleeding occurred in 9 (25%) patients, 
including fatal in 3 (8%) and minor in 6 (17%) cases. 
The fatal surgical site bleeds included pericardial 
tamponade in a patient after coronary artery bypass 
grafting and intracranial hemorrhages in 2 patients 
with recent craniotomy. Transfusion in the absence 
of overt systemic bleeding occurred in 4 (11%) 
patients. Asymptomatic intracranial hemorrhage 
was detected on follow-up CT in 6 (17%) patients. 
Symptomatic intracranial hemorrhage occurred in 
3 (8%) patients and was fatal in 2 (6%).
Conclusion
In patient with ischemic stroke following pacemaker 
implantation and high risk of bleeding, endovascular 
treatment together with intra-arterial thrombolysis 
was safe and effective. 
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